0001840292FALSE00018402922024-01-102024-01-100001840292us-gaap:CommonStockMember2024-01-102024-01-100001840292us-gaap:WarrantMember2024-01-102024-01-100001840292hlg:PreferredSharePurchaseRightMember2024-01-102024-01-10

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 10, 2024

Heliogen, Inc.
(Exact name of registrant as specified in its charter)

Delaware
001-4020985-4204953
(State or other jurisdiction of
incorporation)
(Commission File Number)
(I.R.S. Employer
Identification No.)
130 West Union Street
Pasadena, California 91103
(Address of Principal Executive Offices)
Registrant's telephone number, including area code: (626) 720-4530

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $0.0001 par value per shareHLGN
New York Stock Exchange*
Warrants, each 35 warrants exercisable for one share of common stock at an exercise price of $402.50 per shareHLGN.W
New York Stock Exchange*
Preferred Share Purchase RightsN/A
New York Stock Exchange*
* The registrant’s common stock and warrants began trading exclusively on the over-the-counter market since November 8, 2023 under the symbols “HLGN” and “HLGNW”, respectively.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.

Transition Agreement with Mr. Kurada

On January 11, 2024, Heliogen, Inc. (the “Company”) and Sagar Kurada entered into a transition agreement (the “Transition Agreement”), pursuant to which the Company and Mr. Kurada mutually agreed that Mr. Kurada will cease to serve as Chief Financial Officer and Head of Strategy of the Company, effective January 11, 2024, and will cease employment with the Company, effective January 31, 2024 (the “Separation Date”). The Transition Agreement provides that Mr. Kurada will continue to receive his base salary and benefits eligibility through the Separation Date. Mr. Kurada will not receive a bonus for 2023. Subject to Mr. Kurada’s continued employment through the Separation Date, his execution and non-revocation of a general release of claims in favor of the Company, his compliance with his existing confidentiality obligations and the non-disparagement and other terms of the Transition Agreement, and his continued support to the Company with the orderly transition of his work, Mr. Kurada will receive (i) payments equal to his base salary for two months following the Separation Date; and (ii) payment of his and his dependents’ healthcare premiums pursuant to the Consolidated Omnibus Budget Reconciliation Act for a period of up to two months after the Separation Date. All equity awards granted to Mr. Kurada will be unvested as of the Separation Date and will therefore be canceled.

The Transition Agreement is attached hereto as Exhibit 10.1 and is incorporated herein by reference. The foregoing description of the Transition Agreement is qualified in its entirety by reference to such exhibit.

Appointment of Interim Chief Financial Officer

On January 11, 2024, the Board appointed Alan Gahm as interim Chief Financial Officer of the Company, effective on January 11, 2024. Mr. Gahm will serve as the Company’s principal financial officer until the appointment of his successor.

Mr. Gahm, age 66, has been a financial consultant through consulting firm, A&K Financial Consulting Services, LLC (“A&K Consulting”), since 2022. Prior to A&K Consulting, Mr. Gahm was Global Controller for Ascend Performance Materials from 2016 to 2022. Ascend is a privately held global chemical manufacturer of nylon, intermediates, chemicals, and specialty products. Mr. Gahm was previously Vice President, Controller at Universal Weather and Aviation from 2010 to 2016 and Vice President, Chief Accounting Officer for Integrated Electrical Services from 2008 to 2010. Alan has also previously served as Global Corporate Controller of Kraton Polymers, Chief Operating Officer of Profit Technologies Corporation (an international audit and consulting firm), and Vice President, Finance and Corporate Controller for Koch Industries (KoSa). Prior to these positions, Mr. Gahm worked in several finance management positions for Shell Oil Company. Mr. Gahm previously served as the Interim Chief Accounting Officer at the Company during the third quarter of 2022. Mr. Gahm holds a B.A. in Accounting and Finance from the University of West Florida.

On January 11, 2024, the Company entered into a consulting agreement (the “Consulting Agreement”) with Mr. Gahm and A&K Consulting with respect to Mr. Gahm’s service as the Company’s Interim Chief Financial Officer. Pursuant to the Consulting Agreement, in exchange for Mr. Gahm’s full-time service as the Company’s Interim Chief Financial Officer, Mr. Gahm, through A&K Consulting, will receive a fee of $175.00 per hour. The Consulting Agreement has a term of three months from the date of the Agreement and may be renewed for a successive three (3) month term upon mutual agreement by the parties to the agreement. The Consulting Agreement may be terminated by any party upon fourteen (14) days advance written notice.

The Consulting Agreement is attached hereto as Exhibit 10.2 and is incorporated herein by reference. The foregoing description of the Consulting Agreement is qualified in its entirety by reference to such exhibit.



Appointment of Principal Accounting Officer

On January 11, 2024, the Company appointed Ms. Wilda Siu, age 48, to serve as its Chief Accounting Officer and Head of Business Systems and Information Technology effective January 26, 2024. Ms. Siu will serve as the Company’s principal accounting officer. Ms. Siu replaces Kelly Rosser. On January 10, 2024, Ms. Rosser notified the Company that she will resign as Chief Accounting Officer effective January 26, 2024 to pursue another opportunity.

Ms. Siu has been the Company’s Senior Vice President, Business Systems Transformation & Financial Operations since September 2022. Prior to joining the Company, Ms. Siu was the Vice President, Controller of Vizio Holding Corp., a consumer electronics company, from February 2018 to September 2022. From November 2016 to February 2018, she served as Director of Accounting for Nellson LLC, a food and beverage manufacturing company. Ms. Siu previously served as Director, Business Transformation for Broadcom Inc. from November 2012 to June 2016, and before then, she served as Director, Advisory Services at PricewaterhouseCoopers LLP from February 2006 to November 2012. Ms. Siu holds an M.B.A. in Professional Accounting from the University of Toronto and a Bachelor of Commerce in Accounting and Economics from McGill University.

Mr. Gahm and Ms. Siu will enter into the Company’s standard form of indemnification agreement, the form of which is filed as Exhibit 10.6 to the Company’s Current Report on Form 8-K filed with the SEC on January 6, 2022. Pursuant to the terms of the indemnification agreement, the Company may be required, among other things, to indemnify Mr. Gahm and Ms. Siu for certain expenses, including attorneys’ fees, judgments, fines and settlement amounts incurred by him or her in any action or proceeding arising out of his or her service as an officer of the Company.

There are no arrangements or understandings between Mr. Gahm and any other person pursuant to which Mr. Gahm was appointed as interim Chief Financial Officer and there are no family relationships between Mr. Gahm and any director or other executive officer of the Company, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. There are also no arrangements or understandings between Ms. Siu and any other person pursuant to which Ms. Siu was appointed as Chief Accounting Officer and there are no family relationships between Ms. Siu and any director or other executive officer of the Company, and she has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

Item 7.01 Regulation FD Disclosure.

On January 12, 2024, the Company issued a press release with respect to Mr. Kurada’s departure as Chief Financial Officer, Mr. Gahm’s appointment as Interim Chief Financial Officer and Ms. Siu’s replacement of Ms. Rosser as principal accounting officer, as discussed in Item 5.02 of this Current Report on Form 8-K. A copy of the Company’s press release is being furnished as Exhibit 99.1 to this Form 8-K. The exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.
* Portions of this Exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K.

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Heliogen, Inc.
Dated:January 12, 2024By:/s/ Christiana Obiaya
Christiana Obiaya
Chief Executive Officer

Exhibit 10.1
heliogen.jpg
January 11, 2024
Via Email
Sagar Kurada
Re: Transition Agreement
Dear Sagar:
This letter sets forth the substance of the transition agreement (the “Agreement”) which Heliogen, Inc. (the “Company”) is offering to you to aid in your employment transition.
1.Separation Date. As discussed, you and the Company have mutually agreed to part ways and your employment with the Company will end on January 31, 2024 (the “Separation Date”). You hereby resign from your role as Chief Financial Officer (and from any and all officer positions held by you at the Company or any of its subsidiaries), effective as of the date of this Agreement. Between the date of this Agreement and the Separation Date (the “Transition Period”), you will assist the Company with an orderly transition of your job responsibilities and perform such other transition duties as may be requested by the Company’s Chief Executive Officer (“CEO”) or its Board of Directors (the “Board”). Provided you comply with your obligations during the Transition Period, the Company will also work with you during this time on mutually agreeable internal and external messaging regarding your employment transition from the Company. You will continue to receive your current salary and benefits during the Transition Period, but you acknowledge and agree that you are not eligible for and will not receive a performance bonus for 2023.
2.Accrued Salary. On the Separation Date, the Company will pay you all accrued salary earned through the Separation Date, subject to standard payroll deductions and withholdings. You will receive this payment regardless of whether or not you sign this Agreement. You acknowledge that the Company has a flexible time off policy and you therefore have no accrued and unused vacation or paid time off to be paid out upon separation from employment.
3.Separation Benefits. Although you are not otherwise entitled to any separation or severance benefits, if you (a) timely execute this Agreement and remain employed through the Transition Period, (b) execute the Updated Release of Claims attached to this Agreement as Exhibit A (the “Updated Release”) on or within three (3) days after the Separation Date and allow it to become effective, and (c) otherwise comply fully with your obligations hereunder ((a)‑(c) collectively, the “Separation Criteria”), the Company will provide you with the following separation benefits (the “Separation Benefits”):


(a)Continued Payments. Provided you support the Company with the orderly transition of your work, the Company will provide you with payments equivalent to your base salary in effect as of the Separation Date for two (2) months following the Separation Date. These payments will be made subject to standard payroll deductions and withholdings on the Company’s regular payroll dates, beginning with the first such date to occur at least five (5) business days following the “Effective Date of Updated Release” (as defined in Exhibit A).
(b)COBRA Premium. If you timely elect continued coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) or applicable state law, for you and your covered dependents, the Company will pay, as and when due to the insurance carrier or COBRA administrator (as applicable), the COBRA health insurance premiums for you and your eligible dependents, if any, until the earlier of: (A) two (2) months following the Separation Date, (B) the expiration of your eligibility for the continuation coverage under COBRA, or (C) such time as you become eligible for substantially equivalent health insurance coverage in connection with new employment or self-employment (thereafter, you will be responsible for all COBRA premium payments, if any) (such time, the “COBRA Payment Period”). Notwithstanding the foregoing, if at any time the Company determines, in its sole discretion, that the payment of the COBRA premiums would result in a violation of the nondiscrimination rules of Section 105(h)(2) of the Internal Revenue Code of 1986 or any statute or regulation of similar effect (including but not limited to the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act), then provided you remain eligible for reimbursement in accordance with this Section, in lieu of providing the COBRA premiums, the Company will instead pay you on the last day of each remaining month of the COBRA Payment Period, a fully taxable cash payment equal to the COBRA premiums for that month, subject to applicable tax withholdings for the remainder of the COBRA Payment Period. You may, but are not obligated to, use this payment to pay for medical expenses. If you become eligible for coverage under another employer’s group health plan through self-employment or otherwise cease to be eligible for COBRA during the period provided in this clause, you must immediately notify the Company of such event, and all payments and obligations under this Section will cease.
(c)Mutual Non-Disparagement. As an additional Separation Benefit, the Company will provide you with the mutual non-disparagement benefit described in Section 10(b) below.
4.Benefit Plans. If you are currently participating in the Company’s group health insurance plans, your participation as an employee will end on the last date of the month in which your Separation Date occurs. Thereafter, to the extent provided by the federal COBRA law or, if applicable, state insurance laws, and by the Company’s current group health insurance policies, you will be eligible to continue your group health insurance benefits at your own expense, with the potential for certain payments to be made by the Company pursuant to Section 3(b) above. Later, you may be able to convert to an individual policy through the provider of the Company’s health insurance, if you wish.
You may be eligible for unemployment insurance benefits after the Separation Date. You acknowledge that whether you receive unemployment compensation will be decided by the applicable state agency and not by the Company. Your local state agency charged with Unemployment Insurance matters can provide you with benefits and eligibility information regarding unemployment compensation.


5.Restricted Stock Units. You were originally awarded 750,000 restricted stock units (the “RSUs”) (as adjusted for the Company’s 1-for-35 reverse stock split to 21,428 RSUs) pursuant to the Company’s 2021 Equity Incentive Plan (the “Plan”). Under the Plan, your grant notice and the agreements governing the RSUs (the “RSU Documents”), vesting of the RSUs will cease as of the Separation Date and as of that date, none of the RSUs will have vested.
6.Other Compensation or Benefits. You acknowledge that, except as expressly provided in this Agreement, you will not receive any additional compensation, commission, separation, severance or other payments or benefits after the Separation Date.
7.Expense Reimbursements. You agree that, within ten (10) days of the Separation Date, you will submit your final documented expense reimbursement statement reflecting all business expenses you incurred through the Separation Date, if any, for which you seek reimbursement. The Company will reimburse you for reasonable business expenses pursuant to its regular business practice.
8.Return of Company Property. By the Separation Date, or upon the Company’s earlier request, you agree to return to the Company all Company documents (and all copies thereof) and other Company property that you have had in your possession at any time, including, but not limited to, Company files, notes, drawings, records, business plans and forecasts, financial information, specifications, computer-recorded information, tangible property (including, but not limited to, computers), credit cards, entry cards, identification badges and keys; and any materials of any kind that contain or embody any proprietary or confidential information of the Company (and all reproductions thereof). Please coordinate return of Company property with Christie Obiaya. Receipt of the Separation Benefits described in Section 3 of this Agreement is expressly conditioned upon return of all Company property.
9.Proprietary Information and Post-Employment Obligations. Both during and after your employment you acknowledge your continuing obligations under your Employee Confidentiality & Non-Disclosure Agreement not to use or disclose any confidential or proprietary information of the Company and to refrain from certain solicitation activities. A copy of your Employee Confidentiality & Non-Disclosure Agreement is attached hereto as Exhibit B. If you have any doubts as to the scope of the restrictions in your agreement, you should contact Christie Obiaya immediately to assess your compliance. As you know, the Company will enforce its contract rights. Please familiarize yourself with the enclosed agreement which you signed. Confidential information that is also a “trade secret,” as defined by law, may be disclosed (A) if it is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, in the event that you file a lawsuit for retaliation by the Company for reporting a suspected violation of law, you may disclose the trade secret to your attorney and use the trade secret information in the court proceeding, if you: (A) file any document containing the trade secret under seal; and (B) do not disclose the trade secret, except pursuant to court order.


10.Non-Disparagement.
(a)You agree not to disparage the Company, and the Company’s attorneys, directors, managers, partners, employees, agents and affiliates, in any manner likely to be harmful to them or their business, business reputation or personal reputation; provided that you may respond accurately and fully to any question, inquiry or request for information when required by legal process. Notwithstanding the foregoing, nothing in this Agreement shall limit your right to voluntarily communicate with the Equal Employment Opportunity Commission, the United States Department of Labor, the National Labor Relations Board, the Securities and Exchange Commission, other federal government agency, similar state or local agency, law enforcement, or an attorney you retain, or to discuss the terms and conditions of your employment with others to the extent expressly permitted by Section 7 of the National Labor Relations Act.
(b)If you satisfy the Separation Criteria set forth in Section 3 above, the Company agrees not to disparage you or your agents or representatives after the Separation Date in any manner likely to be harmful to you or your business or personal reputation; provided, however, that the Company may respond accurately and fully to any question, inquiry or request for information when required by legal process. The Company’s obligations under this Section 10(b) are limited to its representatives with knowledge of this provision, including the members of its Board and its executive officers.
11.Cooperation. You agree to reasonably cooperate with the Company in all matters relating to the transition of your work and responsibilities on behalf of the Company, including, but not limited to, any present, prior or subsequent relationships, the orderly transfer of any such work and institutional knowledge to such other persons as may be designated by the Company, and any ongoing investigations or litigation requiring your involvement or assistance, by making yourself reasonably available during regular business hours.
12.Release.
(a)General Release of Claims. In exchange for the consideration provided to you under this Agreement to which you would not otherwise be entitled, you hereby generally and completely release the Company, and its affiliated, related, parent and subsidiary entities, and its and their current and former directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, insurers, affiliates, and assigns (the “Company Parties”) from any and all claims, liabilities, demands, causes of action, and obligations, both known and unknown, arising from or in any way related to events, acts, conduct, or omissions occurring at any time prior to and including the date you sign this Agreement.
(b)Scope of Release. This general release includes, but is not limited to: (i) all claims arising from or in any way related to your employment with the Company, including your Executive Employment Agreement dated July 6, 2023, or the termination of that employment; (ii) all claims related to your compensation or benefits from the Company, including salary, bonuses, commissions, vacation pay, expense reimbursements, severance or separation pay, fringe benefits, stock, stock options, or any other ownership, equity, or profits interests in the Company; (iii) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing; (iv) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (v) all federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990, the California Labor Code, the California Family Rights Act, and the California Fair Employment and Housing Act. You acknowledge


that you have been advised, pursuant to California Government Code Section 12964.5(b)(4), that you have the right to consult an attorney regarding this Agreement and that you were given a reasonable time period of not less than five (5) business days in which to do so. You further acknowledge and agree that, in the event you sign this Agreement prior to the end of the reasonable time period provided by the Company, your decision to accept such shortening of time is knowing and voluntary and is not induced by the Company through fraud, misrepresentation, or a threat to withdraw or alter the offer prior to the expiration of the reasonable time period, or by providing different terms to employees who sign such an agreement prior to the expiration of the time period.
(c)Section 1542 Waiver. In giving the release herein, which includes claims which may be unknown to you at present, you acknowledge that you have read and understand Section 1542 of the California Civil Code, which reads as follows:
“A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party.”
You hereby expressly waive and relinquish all rights and benefits under that Section and any law of any other jurisdiction of similar effect with respect to your release of claims herein, including but not limited to your release of unknown claims.
(d)Exceptions. Notwithstanding the foregoing, you are not releasing the Company hereby from: (i) any claims that may arise from events that occur after the date this waiver is executed; (ii) any obligation to indemnify you pursuant to the Articles and Bylaws of the Company, any valid fully-executed indemnification agreement with the Company, applicable law, or applicable directors and officers liability insurance; (iii) any claims that cannot be waived by law, including, without limitation, any rights you may have under applicable workers’ compensation laws and your right, if applicable, to file or participate in an investigative proceeding of any federal, state, or local government agency; or (iv) any claims for breach of this Agreement.
(e)Protected Rights. You understand that nothing in this Agreement limits your ability to file a charge or complaint with the Equal Employment Opportunity Commission, the Department of Labor, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission or any other federal, state or local governmental agency or commission (“Government Agencies”). You further understand this Agreement does not limit your ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company. While this Agreement does not limit your right to receive an award for information provided to the Securities and Exchange Commission, you understand and agree that, to the maximum extent permitted by law, you are otherwise waiving any and all rights you may have to individual relief based on any claims that you have released and any rights you have waived by signing this Agreement. Nothing in this Agreement prevents you from discussing or disclosing information about unlawful acts in the workplace, such as harassment, or discrimination or any other conduct that you have reason to believe is unlawful. Additionally, nothing in this Agreement waives any rights you may have under Section 7 of the National Labor Relations Act (subject to the release of claims set forth herein).


13.Your Acknowledgments and Affirmations. You acknowledge and agree that (i) the consideration given to you in exchange for the waiver and release in this Agreement is in addition to anything of value to which you were already entitled; (ii) that you have been paid for all time worked, have received all the leave, leaves of absence and leave benefits and protections for which you are eligible, and have not suffered any on-the-job injury for which you have not already filed a claim; (iii) you have been given sufficient time to consider this Agreement and to consult an attorney or advisor of your choosing; and (iv) you are knowingly and voluntarily executing this Agreement waiving and releasing any claims you may have as of the date you execute it. You hereby represent that you have been paid all compensation owed and for all hours worked, you have received all the leave and leave benefits and protections for which you are eligible, pursuant to the Company’s policies, applicable law or otherwise, and you have not suffered any on-the-job injury or illness for which you have not already filed a workers’ compensation claim. You further represent that, as of the date of this Agreement, you have not filed any lawsuits, charges, complaints, petitions, claims or other accusatory pleadings against any of the Company Parties in any court, arbitral forum or with any governmental agency.
14.No Admission. This Agreement does not constitute an admission by the Company of any wrongful action or violation of any federal, state, or local statute, or common law rights, including those relating to the provisions of any law or statute concerning employment actions, or of any other possible or claimed violation of law or rights.
15.Breach. You agree that upon any breach of this Agreement you will forfeit all amounts paid or owing to you under this Agreement. Further, you acknowledge that it may be impossible to assess the damages caused by your violation of the terms of Sections 8, 9, 10 and 11 of this Agreement and further agree that any threatened or actual violation or breach of those Sections of this Agreement will constitute immediate and irreparable injury to the Company. You therefore agree that any such breach of this Agreement is a material breach of this Agreement, and, in addition to any and all other damages and remedies available to the Company upon your breach of this Agreement, the Company shall be entitled to an injunction to prevent you from violating or breaching this Agreement. The parties agree that if either party is successful in whole or part in any legal or equitable action to enforce this Agreement, then the enforcing party is entitled to recover from the other party all of the costs, including reasonable attorneys’ fees, incurred in enforcing the terms of this Agreement.
16.Section 409A. It is intended that all of the separation payments and benefits payable under Section 3 of this Agreement satisfy, to the greatest extent possible, the exemptions from the application of Section 409A of the Code and the regulations and other guidance thereunder and any state law of similar effect (collectively, “Section 409A”) provided under Treasury Regulations Sections 1.409A-1(b)(4) and 1.409A-1(b)(9), and this Agreement will be construed in a manner that complies with Section 409A.


17.Miscellaneous. This Agreement, including Exhibits A and B, constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with regard to this subject matter. It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations. This Agreement may not be modified or amended except in a writing signed by both you and a duly authorized officer of the Company. This Agreement will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns. If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question will be modified by the court so as to be rendered enforceable. This Agreement will be deemed to have been entered into and will be construed and enforced in accordance with the laws of the State of California as applied to contracts made and to be performed entirely within California.
If this Agreement is acceptable to you, please sign below and return it to me on or before the date that is five (5) days after you receive this Agreement. The Company’s offer of Separation Benefits contained herein will automatically expire if you do not sign and return the fully-signed Agreement within this timeframe.
I wish you all the best in your future endeavors.
[signatures to follow on next page]




Sincerely,

Heliogen, Inc.
By:/s/ Christie Obiaya
Christie Obiaya
Chief Executive Officer
AGREED TO AND ACCEPTED:

/s/ Sagar Kurada
Sagar Kurada
Date:January 11, 2024


Exhibit A – Updated Release of Claims
Exhibit B – Employee Confidentiality & Non-Disclosure Agreement


EXHIBIT A
UPDATED RELEASE OF CLAIMS
(To be signed and returned to the Company on or within three (3) days after the Separation Date and in no event before the Separation Date)
Heliogen, Inc. (the “Company”) and Sagar Kurada (the “Employee”) entered into a Transition Agreement dated January 11, 2024 (the “Transition Agreement”). The parties to that Transition Agreement hereby further agree as follows:
1. A blank copy of this Updated Release of Claims (“Updated Release”) was attached to the Agreement as Exhibit A and the parties agree that it is part of the Agreement.
2. In consideration of the Separation Benefits, Employee hereby extends the release of claims in Section 12 of the Agreement to any claims that arose through the date he signs this Updated Release and extends the representations he has made in Section 13 of the Agreement through the date he signs this Updated Release.
3. Employee also hereby extends the release of claims in Section 12 of the Agreement to any and all Claims under the federal Age Discrimination in Employment Act, as amended (“ADEA”). Employee acknowledges that he is knowingly and voluntarily waiving and releasing any rights he may have under the ADEA, and that the consideration given for this Updated Release is in addition to anything of value to which he was already entitled. Employee further acknowledges that he has been advised by this writing, as required by the ADEA, that: (1) this Updated Release does not apply to any rights or claims that arise after the date he signs this Updated Release; (2) Employee should consult with an attorney prior to signing this Updated Release; (3) Employee has been given more than twenty-one (21) calendar days to consider this Updated Release (although he may choose to voluntarily execute this Updated Release earlier, though not earlier than the Separation Date); (4) Employee has seven (7) calendar days following the date he signs this Updated Release to revoke it; and (5) this Updated Release will not be effective until the date upon which the revocation period has expired unexercised (the “Effective Date of Updated Release”), which will be the eighth (8th) calendar day after Employee signs it.
4. The parties agree that this Updated Release is a part of the Transition Agreement.
Understood, Accepted and Agreed:
Heliogen, Inc.Employee
By:By:
Name:Christie ObiayaSagar Kurada
Title:Chief Executive Officer
Dated:Dated:


EXHIBIT B

Employee Confidentiality & Non-Disclosure Agreement


Exhibit 10.2
CONSULTING AGREEMENT
This Consulting Agreement (“Agreement”) is made by and between A&K Financial Consulting Services, LLC (“A&K Consulting”), Alan Gahm (“Gahm”) (A&K Consulting and Gahm collectively, the “Consultant”), and Heliogen, Inc. (“Client”). Consultant and Client are sometimes collectively referred to as the “Parties” or singularly as a “Party.” In consideration of the mutual promises contained in this Agreement, the Parties agree as follows:
1.Scope of Services
a.A&K Consulting shall provide Client the consulting services of Gahm, A&K Consulting’s sole member. Gahm will perform all duties and fulfill the responsibilities typically completed or required of a Chief Financial Officer of a public company in the United States, including, but not limited to, oversight of the Client’s accounting and finance organization (including Treasury and Tax functions), financial and accounting compliance functions, preparing the Client’s financial statements and signing the Client’s reports to be filed with the Securities and Exchange Commission (for instance on Forms 10-Q, 10-K and 8-K), communicating with shareholders, assisting in financing or other strategic transactions, coordinating with the Client’s independent public accountants with respect to quarterly reviews and annual audits, coordinating with the Chairman of the Audit Committee and providing all information necessary, appropriate or required for the Audit Committee, and such other duties reasonably requested by the Client’s corporate officers or Board of Directors, consistent with the position of Chief Financial Officer (the “Services”). Consultant shall render the Services as an independent contractor to Client. Consultant acknowledges and agrees that Gahm will use his own independent discretion in performing the Services, within the scope of the Services specified by the Client. The Services under this Agreement will all be performed exclusively by Gahm and may not be subcontracted or assigned to other persons. Gahm will provide the Services on a full-time basis, devoting all necessary time to satisfactorily perform the Services. Gahm shall, and A&K Consulting shall cause Gahm to, exercise reasonable skill and care in providing the Services hereunder and to perform the Services in a professional manner, consistent with industry standards. Gahm will report directly to the Client’s Chief Executive Officer (“CEO”).
b.If and to the extent requested by the CEO or Board of Directors, following the termination of this Agreement, Consultant will provide such assistance and certifications as may be requested or necessary in order to enable the Client to make timely filing of its next succeeding quarterly or annual report on Form 10-Q or 10-K, respectively, required to be filed by the Client following the termination of this Agreement. To the extent that Consultant is requested to provide such assistance and certifications, Consultant shall be compensated at the same rate as for the Services as described herein, pro-rated based on the time spent in so doing, and for purposes of this Agreement, such additional assistance and services shall be deemed to be part of the Services hereunder.
c.The Services will be rendered from the Client’s location, as requested by the Client, and subject to change as necessary to carry out the Services.
2.Compensation
a.As consideration for the Services, the Client shall pay A&K Consulting a fee of $175 per hour. A&K Consulting shall submit invoices to the Client, payable in thirty (30) days from the invoice date. The Client agrees to reimburse A&K Consulting for reasonable travel-related (non-commuting expenses) and out of pocket expenses that are incurred by Gahm with the performance of the Services,
1

provided Gahm receives prior written consent from an authorized agent of the Client prior to incurring such expenses. Expenses include but are not limited to: reproduction, shipping, postage, software, mileage, tolls, cab fares, parking, hotel, meals during travel, airline travel, and other similar expenses related to the Services. A&K Consulting will maintain adequate documentation and records to support all expenses invoiced to the Client including receipts for travel-related expenses.
b.If a Party hereto brings any action to enforce its rights hereunder, the prevailing Party shall be entitled to recover its reasonable attorneys’ fees and costs incurred in connection with such action.
c.Payments to A&K Consulting under this Agreement shall not be subject to withholding of state or federal taxes of any kind. All taxes are the sole responsibility of Consultant. Consultant represents, warrants and covenants to the Client that it has paid and shall continue to pay all taxes owed by it and has filed and shall continue to file all reports required to be filed by it with respect to the Services. Consultant agrees that it (including any employees, contractors, agents, or affiliates of Consultant) will not be eligible for any employee benefits of the Client.
3.Term and Termination. The term (the “Term”) of this Agreement shall begin January 11, 2024, and shall continue for a period of three (3) consecutive months, unless terminated by a Party under the terms of this Agreement. This Agreement may be renewed for successive three (3) month Term if agreed to in writing by the Parties. The Parties may terminate this Agreement with fourteen (14) days written notice. Upon termination, A&K Consulting shall be entitled to receive compensation and reimbursement for any Services and expenses accrued, but not paid by the Client.
4.Confidentiality. The Parties acknowledge that there is an exchange of confidential information associated with this Agreement. Consultant agrees to hold Client’s Confidential Information (as defined below) in strict confidence and not to disclose such Confidential Information to any third parties. Consultant also agrees not to use any of Client’s Confidential Information for any purpose other than performance of Consultant’s Services hereunder. “Confidential Information” as used in this Agreement shall mean all information disclosed by Client to Consultant, or otherwise, regarding Client, Client’s business, as well as Client’s subsidiaries and affiliates, obtained by Consultant pursuant to Services provided under this Agreement that is not generally known in the Client’s trade or industry and shall include, without limitation, (a) concepts and ideas relating to the development and distribution of content in any medium or to the current, future and proposed business activities of Client or its subsidiaries and affiliates; (b) trade secrets, drawings, inventions, know-how, software programs, intellectual property rights, and software source documents; (c) information regarding plans for research, development, investments, dispositions, acquisitions, marketing and selling, business plans, business forecasts, budgets and unpublished financial statements, licenses and distribution arrangements, prices and costs, suppliers and customers; (d) any information regarding the skills and compensation of employees, contractors or other agents of the Client or its subsidiaries and, affiliates and (f) any other non-public information that a competitor of the Client could use to the Client’s competitive disadvantage or the competitive disadvantage of any of the Client’s subsidiaries or affiliates. Confidential Information also includes proprietary or confidential information of any third party who may disclose such information to Client or Consultant in the course of the Client’s business. Consultant’s obligations set forth in this Section 4 shall not apply with respect to any portion of the Confidential Information that the Consultant can document that such portion: (i) is in the public domain through no fault of the Consultant; (ii) has been rightfully independently communicated to the Consultant free of any obligation of confidence; or (iii) was developed by the Consultant independently of and without reference to any information communicated to the Consultant by the Client. All Confidential Information furnished to Consultant by Client is the sole
2

and exclusive property of Client or, as applicable, such subsidiary, affiliate, supplier, customer, or third-party. Upon request by Client, Consultant agrees to promptly deliver to Client the original and any copies of such Confidential Information. Notwithstanding the foregoing, the obligations of confidentiality and non-use with respect to Confidential Information required by this Section 4 shall not apply to any Confidential Information required to be disclosed pursuant to a subpoena in any court or administrative proceeding, if sought in an oral deposition, or is otherwise required to be disclosed by law, in any such case only after giving Client as much advance notice of any such potential disclosure to permit the Client to seek a protective order limiting or preventing the disclosure. Additionally, nothing herein shall restrict Consultant from engaging in the activities set forth in Section 10 or engaging in any other legally protected activity. Additionally, and notwithstanding the foregoing, pursuant to 18 U.S.C. Section 1833(b), Consultant shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that: (1) is made in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (2) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
5.Work Product. Client shall own all right, title and interest (including patent rights, copyrights, trade secret rights, mask work rights, trademark rights and all other intellectual property rights of any sort throughout the world) relating to any and all inventions (whether or not patentable), works of authorship, mask works, designations, designs, know-how, ideas, concepts, techniques and information made or conceived or reduced to practice, in whole or in part, by Consultant during the Term of this Agreement and that arise out of the Services or any Confidential Information (as defined below)(collectively, “Inventions”) and Consultant will promptly disclose and provide all Inventions to Client upon written request. Consultant shall further assist Client, at Client’s expense, to further evidence, record and perfect such assignments, and to perfect, obtain, maintain, enforce, and defend any rights assigned.
6.Non-Interference. During the Term of this Agreement, and for one year immediately following the expiration of the Term, Consultant agrees not to interfere with the business of Client by soliciting or attempting to attempt to solicit any employee, consultant, or independent contractor of Client to terminate such person’s employment or service in order to become an employee, consultant, or independent contractor to or for any other person or entity.
7.Nature of Relationship. Consultant is retained as an independent contractor, not as an employee, joint venture, partnership, or agent of any kind. Consultant shall not act as an agent on behalf of Client or shall be deemed to have the authority or right to act for or on behalf of Client except as provided in this Agreement or otherwise without Client’s prior written consent.
8.Indemnity. Consultant and the Client will promptly enter into an indemnification agreement in substantially the same form provided to other similarly situated officers of the Client and such agreement shall include indemnification of Consultant in connection with any claims against Consultant in Gahm’s capacity as an officer of the Client.
9. Remedies. In the event of a breach of the terms of this Agreement (Sections 4, 5, 6) by Consultant the parties hereto acknowledge and agree that it would be difficult to measure the damage to the Company from such breach, that injury to the Company from such breach would be impossible to calculate and that monetary damages would therefore be an inadequate remedy for any breach. Accordingly, the Company, in addition to any and all other rights which may be available may be entitled to injunctive relief or other similar remedy specifically to enforce Sections 4, 5, and/or 6. Nothing
3

contained herein shall preclude the Client from seeking monetary damages of any kind, including reasonable fees and expenses of counsel and other expenses, in a court of law.
10.Reports to Government Entities. Nothing in this Agreement shall restrict or prohibit Consultant from initiating communications directly with, responding to any inquiries from, providing testimony before, providing confidential information to, reporting possible violations of law or regulation to, or from filing a claim or assisting with an investigation directly with a self-regulatory authority or a government agency or entity, including the U.S. Equal Employment Opportunity Commission, the Department of Labor, the National Labor Relations Board, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General (collectively, the “Regulators”), or from making other disclosures that are protected under the whistleblower provisions of state or federal law or regulation. Client to engage in such communications with the Regulators, respond to such inquiries from the Regulators, provide confidential information or documents to the Regulators, or make any such reports or disclosures to the Regulators. Consultant is not required to notify the Client that Consultant has engaged in such communications with the Regulators.
11.Other Provisions
a.Notice. Any notices and other communications under this Agreement shall be deemed to have been duly given if in writing and: (i) delivered in person and a receipt is given; (ii) if sent by electronic transmission and receipt confirmation is received; or (iii) if sent by registered or certified mail, return receipt requested, postage prepaid, in each case to the appropriate addresses and email addresses set forth below (or to such other addresses as a Party may designate by notice to the other Party):
To ConsultantTo Client
Alan GahmHeliogen, Inc.
130 West Union Street
Pasadena, CA 91103
Attn: General Counsel
Email: legal@heliogen.com
b.Third-Party Beneficiaries. Except as otherwise provided in this Agreement, this Agreement is intended to benefit only the Parties and may be enforced solely by the Parties, their successors in interest or permitted assigns. It is not intended to, and shall not, create rights, remedies or benefits of any character whatsoever in favor of any persons, corporations, associations, or entities other than the Parties, except as provided herein.
c.Waiver. Any waiver by a Party of a breach of any provision of this Agreement will not operate or be construed as a waiver of any subsequent breach of such provision or any other provision of this Agreement. No such waiver shall be effective unless in writing and then only to the extent expressly set forth in writing.
d.Entire Agreement. This Agreement constitutes the entire agreement between the Parties as to the subject matter hereof and supersedes all prior agreements, whether oral or written, with respect to this subject matter. This Agreement may be amended only in a written amendment executed by all of the Parties to this Agreement.
4

e.Assignment. Consultant may not its rights or obligations hereunder without the express written consent of the Client. The Client may assign this Agreement to an affiliate or in the event of a corporate transaction, reorganization, or restructuring upon prior written notice to the Consultant.
f.Severability. If any one or more of the provisions contained in this Agreement shall for any reason be held to be invalid, illegal or unenforceable in any respect by a judicial body, such holding shall not affect the validity and enforceability of any other provisions hereof. Further, should any provisions within this Agreement ever be reformed or rewritten by a judicial body, such provisions as so rewritten shall be binding upon the Parties hereto.
g.Arbitration. Consultant and the Client agree that any and all disputes, claims, or causes of action, in law or equity, including but not limited to statutory claims, arising from or relating to the enforcement, breach, performance, or interpretation of this Agreement, Consultant’s engagement with the Client, or the termination of Consultant’s engagement, shall be resolved pursuant to the Federal Arbitration Act, 9 U.S.C. § 1-16, to the fullest extent permitted by law, by final, binding and confidential arbitration conducted by JAMS or its successor, under JAMS’ then applicable rules and procedures before a single arbitrator (available upon request and also currently available at http://www.jamsadr.com/rules-comprehensiv-arbitration/), or such other rules and procedures as may be required by law or agreed upon by the Parties. Consultant acknowledges that by agreeing to this arbitration procedure, both Consultant and the Client waive the right to resolve any such dispute through a trial by jury or judge or administrative proceeding. In addition, all claims, disputes, or causes of action under this section, whether by Consultant or the Client, must be brought in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member in any purported class or representative proceeding, nor joined or consolidated with the claims of any other person or entity. The arbitrator may not consolidate the claims of more than one person or entity and may not preside over any form of representative or class proceeding. To the extent that the preceding sentences regarding class claims or proceedings are found to violate applicable law or are otherwise found unenforceable, any claim(s) alleged or brought on behalf of a class shall proceed in a court of law rather than by arbitration. This Section 10(g) shall not apply to any action or claim that cannot be subject to mandatory arbitration as a matter of law, to the extent such claims are not permitted by applicable law(s) to be submitted to mandatory arbitration and the applicable law(s) are not preempted by the Federal Arbitration Act or otherwise invalid (collectively, the “Excluded Claims”). In the event Consultant intends to bring multiple claims, including any Excluded Claim(s), the Excluded Claim(s) may be filed with a court, while any other claims will remain subject to mandatory arbitration. Questions of whether a claim is subject to arbitration under this agreement shall be decided by the arbitrator. Likewise, procedural questions which grow out of the dispute and bear on the final disposition are also matters for the arbitrator. The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written statement signed by the arbitrator regarding the disposition of each claim and the relief, if any, awarded as to each claim, the reasons for the award, and the arbitrator’s essential findings and conclusions on which the award is based. The arbitrator shall be authorized to award all relief that Consultant or the Client would be entitled to seek in a court of law. The Parties equally share the cost of all JAMS arbitration fees and share bear their own attorney fees and costs, unless expressly provided for in this Agreement. Nothing in this agreement to arbitrate is intended to prevent either Consultant or the Client from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. Any awards or orders in such arbitrations may be entered and enforced as judgments in the federal and state courts of any competent jurisdiction.
5

h.Jurisdiction and Venue. This Agreement shall be governed by the laws of the State of Texas. THE PARTIES AGREE THAT IF IT BECOMES NECESSARY FOR ANY OF THE PARTIES TO FILE AN ACTION TO OBTAIN INJUNCTIVE RELIEF OR FOR EXCLUDED CLAIMS AS PERMITTED BY SECTION 10(g) THAT SUCH ACTION SHALL BE BROUGHT EXCLUSIVELY IN HARRIS COUNTY, TEXAS, AND THAT VENUE IS PROPER IN HARRIS COUNTY, TEXAS.
[Signature page to follow]


6

A&K FINANCIAL CONSULTING
SERVICES, LLC		HELIOGEN, INC.
By:/s/ Alan GahmBy:/s/ Christie Obiaya
Alan O. GahmChristie Obiaya, Chief Executive Officer
Date:January 11, 2024Date:January 11, 2024
7
Exhibit 99.1
Heliogen Announces CFO Transition

Sagar Kurada Steps Down;
Alan Gahm Appointed Interim CFO and Wilda Siu Promoted to Chief Accounting Officer

PASADENA, Calif., January 12, 2024 – Heliogen, Inc. (“Heliogen” or the “Company”) (OTCQX: HLGN), a leading provider of AI-enabled concentrating solar energy technology, today announced that the Company and its Chief Financial Officer, Sagar Kurada have mutually agreed for Mr. Kurada to transition out of his role, effective January 11, 2024. Mr. Kurada will support the Company during a transition period to ensure an orderly exit. The Company has initiated a formal search process for Mr. Kurada’s permanent replacement.

Alan Gahm, a veteran finance executive with over 35 years of experience, has been appointed Interim Chief Financial Officer, effective January 11, 2024. Mr. Gahm’s depth of expertise includes accounting and controllership, financial planning and analysis, operations finance, treasury, and M&A. He has held financial leadership roles in the industrial and energy sectors at companies such as Ascend Performance Materials, Koch Industries, and Shell. He previously served as Interim Chief Accounting Officer at Heliogen during the third quarter of 2022.

“I want to thank Sagar for his contributions to Heliogen during his tenure. We wish him the best in his future endeavors,” said Christie Obiaya, Chief Executive Officer of Heliogen. “I would also like to thank Alan for stepping into the Interim CFO role. I am confident Alan’s prior experience with Heliogen will support a smooth transition during our permanent CFO search, as we continue to execute on our strategic plan and growth initiatives.”

Heliogen also announced that Wilda Siu, who currently serves as the Company’s Senior Vice President, Business Systems Transformation & Financial Operations, will be promoted to the role of Chief Accounting Officer and Head of Business Systems and Information Technology, effective January 26, 2024. She will replace Kelly Rosser, who has informed the Company of her intent to resign from that role. Ms. Siu has been the Company’s Senior Vice President, Business Systems Transformation & Financial Operations, since September 2022. Prior to joining Heliogen, Ms. Siu held senior accounting and finance roles at Vizio Holding Corp. (NYSE: VZIO) – including accounting leadership through Vizio’s initial public offering, Nellson LLC and Broadcom Inc. Ms. Siu, who is a Certified Public Accountant (CPA), holds an M.B.A. in Professional Accounting from the University of Toronto and a Bachelor of Commerce in Accounting and Economics from McGill University.

About Heliogen

Heliogen is a renewable energy technology company focused on decarbonizing industry and empowering a sustainable civilization. The company’s concentrating solar energy and thermal storage systems aim to deliver carbon-free heat, steam, power, or green hydrogen at scale to support round-the-clock industrial operations. Powered by AI, computer vision and robotics, Heliogen is focused on providing robust clean energy solutions that accelerate the transition to renewable energy, without compromising reliability, availability, or cost. For more information about Heliogen, please visit heliogen.com.

Forward Looking Statements

This press release includes “forward-looking statements” for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Statements that are not historical in nature, including the words “may,” “will,” “anticipate,” “intend,” “expect” and other similar expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the transition of the Chief Financial Officer position. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: i) our financial and business performance, including risk of uncertainty in our financial projections and business metrics and any underlying assumptions thereunder; (ii)


the delisting of our common stock on the New York Stock Exchange; (iii) changes in our business and strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; (iv) our ability to execute our business model, including market acceptance of our planned products and services and achieving sufficient production volumes at acceptable quality levels and prices; (v) our ability to access sources of capital to finance operations, growth and future capital requirements; (vi) our ability to maintain and enhance our products and brand, and to attract and retain customers; (vii) our ability to scale in a cost effective manner; (viii) changes in applicable laws or regulations; (ix) developments and projections relating to our competitors and industry; (x) unexpected adjustments and cancellations related to our backlog; and (xi) our ability to protect our intellectual property. You should carefully consider the foregoing factors and the other risks and uncertainties disclosed in the “Risk Factors” section in Part I, Item 1A in our Annual Report on Form 10-K for the year ended December 31, 2022, as supplemented in our Quarterly Report on Form 10-Q for the quarters ended March 31, 2023 and September 30, 2023, and other documents filed by the Company from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Heliogen Investor Contact:
Louis Baltimore
VP, Strategic Finance & Investor Relations
Louis.Baltimore@heliogen.com

Heliogen Media Contact:
Longacre Square Partners
Joe Germani / Miller Winston
heliogen@longacresquare.com

v3.23.4
Cover
Jan. 10, 2024
Document Information [Line Items]  
Document Type 8-K
Document Period End Date Jan. 10, 2024
Entity Registrant Name Heliogen, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-40209
Entity Tax Identification Number 85-4204953
Entity Address, Address Line One 130 West Union Street
Entity Address, City or Town Pasadena
Entity Address, State or Province CA
Entity Address, Postal Zip Code 91103
City Area Code 626
Local Phone Number 720-4530
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period true
Entity Central Index Key 0001840292
Amendment Flag false
Common Stock  
Document Information [Line Items]  
Title of 12(b) Security Common stock, $0.0001 par value per share
Trading Symbol HLGN
Security Exchange Name NYSE
Warrant  
Document Information [Line Items]  
Title of 12(b) Security Warrants, each 35 warrants exercisable for one share of common stock at an exercise price of $402.50 per share
Trading Symbol HLGN.W
Security Exchange Name NYSE
Preferred Share Purchase Right  
Document Information [Line Items]  
Title of 12(b) Security Preferred Share Purchase Rights
No Trading Symbol Flag true
Security Exchange Name NYSE
Heliogen (QX) (USOTC:HLGN)
Historical Stock Chart
Von Nov 2024 bis Dez 2024 Click Here for more Heliogen (QX) Charts.
Heliogen (QX) (USOTC:HLGN)
Historical Stock Chart
Von Dez 2023 bis Dez 2024 Click Here for more Heliogen (QX) Charts.